Transcept Pharmaceuticals Inc
SEC CIK 1178711 · TSPT · last insider filing 2023-09-21
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Bigham Michael | Director · Exec. Chairman of the Board | filed 2014 - 2023 |
| Franson Timothy R | Director | filed 2015 - 2023 |
| Stein Jeffrey | Director | filed 2014 - 2023 |
| Peterson Kristine | Director | filed 2016 - 2023 |
| Dietz Thomas John | Director | filed 2013 - 2023 |
| Radie Robert S | Director | filed 2014 - 2023 |
| Loh Evan | Director · See Remarks | filed 2014 - 2023 |
| Hoffmann Rolf K | Director | filed 2018 - 2023 |
| Baylor-Henry Minnie | Director | filed 2021 - 2023 |
| Lim Richard J. | Director | filed 2014 - 2016 |
| Kiley Thomas | Director | filed 2009 - 2014 |
| Oclassen Glenn A | Director · President and CEO | filed 2009 - 2014 |
| Raab G Kirk | Director | filed 2009 - 2014 |
| Loar Matthew M | Director | filed 2013 - 2014 |
| Ruegsegger Frederick J | Director | filed 2008 - 2014 |
| Nunn Jason Raleigh | Director | filed 2009 - 2014 |
| Ehrlich Christopher B | Director | filed 2009 - 2013 |
| Laporte Kathleen | Director | filed 2009 - 2012 |
| Turner Daniel K III | Director | filed 2009 - 2011 |
| Walker John Peter | Director · Interim CEO | filed 2006 - 2011 |
| Samuels Camille D | Director | filed 2006 - 2011 |
| Raab Michael | Director | filed 2006 - 2009 |
| Blair James C | Director | filed 2006 - 2009 |
| Sears Lowell | Director | filed 2006 - 2008 |
| Hemberger Judith A | Director | filed 2007 - 2008 |
| Healy James | Director | filed 2006 - 2008 |
| Weber Eckard | Director | filed 2006 - 2008 |
| Bradbury Daniel | Director | filed 2006 - 2008 |
| Moorin Jay | Director | filed 2006 - 2007 |
| Goodwin Bradford S | Director · Chief Executive Officer | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Haskel William M. | Sr. VP, Sec. & General Counsel | filed 2015 - 2023 |
| Woodrow Adam | VP & Chief Commercial Officer | filed 2015 - 2023 |
| Brenner Randall B. | Chief Development & Regulatory | filed 2019 - 2023 |
| Pagan Douglas W. | Chief Financial Officer | filed 2014 - 2019 |
| Boxmeyer Kathryn M. | See Remarks | filed 2014 - 2014 |
| Patterson Leone D | Vice President, CFO | filed 2012 - 2014 |
| Kollins John A | SVP, Chief Business Officer | filed 2012 - 2014 |
| Singh Nikhilesh N | SVP & Chief Scientific Officer | filed 2009 - 2014 |
| Soloway Thomas P | SVP, Operations and CFO | filed 2009 - 2013 |
| Wortzman Marilyn E | VP, Finance | filed 2009 - 2012 |
| Kennedy Joseph T | VP and General Counsel | filed 2009 - 2011 |
| Moore Terrence O | VP, Marketing and Sales | filed 2009 - 2011 |
| Koppy Susan | VP, Corporate Development | filed 2009 - 2009 |
| Albini Edward C | V.P., Chief Financial Officer | filed 2006 - 2008 |
| Singh Amar P | Chf. Commercialization Officer | filed 2006 - 2008 |
| Schnipper Edward F. | Executive VP, CMO | filed 2007 - 2007 |
| Ang Ivy | V.P., Human Resources | filed 2006 - 2007 |
| Curd John G | President, CMO | filed 2006 - 2007 |
| Clow Fong Wang | Senior V.P., Development | filed 2006 - 2007 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.